Using proprietary cultivation methods devised to optimize production of bioactive metabolites, Naicons' strains are used to generate a library of dried microbial extracts in ready-to-screen, 96-well microplates. Different extraction procedures are applied to cultures, ensuring compatibility with most screening assays. Pre-fractionated extracts are also produced.